http://www.cnbc.com/id/39948457?__source=yahoo|headline|quote|text|&par=yahoo I have invested real money in this stock. The drug is both safe and effective. FDA approval is one catalyst for higher stock price for current phase III drug, plus they have another blockbuster in their pipeline waiting for phase III trials. However, the new information from an analyst is once the 1st drug is approved, there could be a possible bidding war on the stock. i think this could easily drive it up to around $ 10/sh sooner rather than later. I was able to get in at lower prices based on my thoughts of very good chance of FDA approval, and I had to sit through a draw down on a 3 month delay, but with this new information, I think even those buying now have great risk vs reward for this stock going forward.